Prosecution Insights
Last updated: October 25, 2026

Kern Kendrick, LLC

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

8 pending office actions • 5 clients • 8 examiners • 5 art units • 0 of 8 (0%) have an AI response strategy ready

Analysis

Kern Kendrick, LLC handles Biotechnology & Pharmaceuticals matters and reports 8 pending office actions across 249 career applications. The profile records current activity and a defined application history.

The resolved allowance rate is 70.69%, and the average is 2.56 office actions per allowance. Practitioners can use the outcome measure and action average together when assessing resolved prosecution behavior.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=249 apps, methodology: how we score firms)

70.7%
Allowance Rate
n=249
+0.27σ
Allowance Rate (norm)
n=249
2.6
OAs to Allowance
n=82
-0.49σ
OAs to Allow (norm)
n=82
750 days
Time to Allowance
n=82
+31.1pp
Interview Lift
n=249
19.8%
RCE Rate
n=249
0.0%
Appeal Rate
n=249

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=16 (min 20)
64.1%
§102 Overcome
n=39
50.0%
§103 Overcome
n=80
56.3%
§112 Overcome
n=71

Specialization & Scale

A61K, G01N, A61P
Top CPC Subclasses
17%
Top-3 CPC Share
n=249
1
Practitioners
n=249
249.0
Apps / Practitioner
n=249

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
2
Medium (25%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (12%)
§112 only1 (12%)
Double-patenting + other1 (12%)
Multi-statute (no §101)5 (62%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
38% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AYALA DELGADO, ANTHONY 1 79.7% +17.1%
YUEN, JACKY 1 35.2% +50.9%
KASSA, TIGABU 1 36.7% +27.9%
KIM, DANIELLE A 1 36.6% +51.9%
BASQUILL, SEAN M 1 38.8% +21.7%
WAN, DEMING 1 76.5% +42.2%
ARNOLD, ERNST V 1 48.2% +12.8%
LAU, JASON 1 54.1% +15.9%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19043217 PROCESS FOR EVAPORATIVE CASTING YUEN, JACKY 146d overdue
18467283 MICROSPHERE FORMULATIONS COMPRISING NALTREXONE AND METHODS FOR MAKING AND USING THE SAME ARNOLD, ERNST V 2d overdue
19634452 SYSTEMS, METHODS, AND APPARATUSES FOR ADSORBING CARBON FROM ENGINE EXHAUST GASES AYALA DELGADO, ANTHONY —
18756907 MICROSPHERE FORMULATIONS COMPRISING KETAMINE AND METHODS FORMAKING AND USING THE SAME KASSA, TIGABU —
18713417 MICROSPHERE FORMULATIONS COMPRISING ASENAPINE AND METHODS FOR MAKING AND USING THE SAME KIM, DANIELLE A —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19043217 PROCESS FOR EVAPORATIVE CASTING YUEN, JACKY 146d overdue
18467283 MICROSPHERE FORMULATIONS COMPRISING NALTREXONE AND METHODS FOR MAKING AND USING THE SAME ARNOLD, ERNST V 2d overdue
18299001 SYSTEMS AND METHODS FOR DRYING PLANT MATERIAL USING MOLECULAR SIEVES LAU, JASON 70d
19634452 SYSTEMS, METHODS, AND APPARATUSES FOR ADSORBING CARBON FROM ENGINE EXHAUST GASES AYALA DELGADO, ANTHONY —
18756907 MICROSPHERE FORMULATIONS COMPRISING KETAMINE AND METHODS FORMAKING AND USING THE SAME KASSA, TIGABU —
18713417 MICROSPHERE FORMULATIONS COMPRISING ASENAPINE AND METHODS FOR MAKING AND USING THE SAME KIM, DANIELLE A —
18674044 MICROSPHERE FORMULATIONS COMPRISING LURASIDONE AND METHODS FOR MAKING AND USING THE SAME BASQUILL, SEAN M —
18671687 SYSTEM AND METHOD FOR REDUCTION OF MOISTURE IN POROUS MATERIALS WAN, DEMING —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
16132
37622
37461
17351
16141

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19634452 SYSTEMS, METHODS, AND APPARATUSES FOR ADSORBING CARBON FROM ENGINE EXHAUST GASES Co2 Filter, LLC AYALA DELGADO, ANTHONY 3746 §102§103§112 Non-Final OA — Pending Mar 31, 2026
19043217 PROCESS FOR EVAPORATIVE CASTING Skuld LLC YUEN, JACKY 1735 §103§112 Non-Final OA 146d overdue Pending Jan 31, 2025
18756907 MICROSPHERE FORMULATIONS COMPRISING KETAMINE AND METHODS FORMAKING AND USING THE SAME Oakwood Laboratories, LLC KASSA, TIGABU §103§112Other Non-Final OA — Pending Jun 27, 2024
18713417 MICROSPHERE FORMULATIONS COMPRISING ASENAPINE AND METHODS FOR MAKING AND USING THE SAME Oakwood Laboratories, LLC KIM, DANIELLE A 1613 §103§112 Non-Final OA — Pending May 24, 2024
18674044 MICROSPHERE FORMULATIONS COMPRISING LURASIDONE AND METHODS FOR MAKING AND USING THE SAME Oakwood Laboratories, LLC BASQUILL, SEAN M 1614 §103DP Non-Final OA — Pending May 24, 2024
18671687 SYSTEM AND METHOD FOR REDUCTION OF MOISTURE IN POROUS MATERIALS Eambient, Inc. WAN, DEMING 3762 §112 Non-Final OA — Pending May 22, 2024
18467283 MICROSPHERE FORMULATIONS COMPRISING NALTREXONE AND METHODS FOR MAKING AND USING THE SAME Oakwood Laboratories, LLC ARNOLD, ERNST V 1613 §102§103§112 Final Rejection 2d overdue Pending Sep 14, 2023
18299001 SYSTEMS AND METHODS FOR DRYING PLANT MATERIAL USING MOLECULAR SIEVES Opcip-Holdco, LLC LAU, JASON 3762 §103 Final Rejection 70d Pending Apr 11, 2023

Managing Kern Kendrick, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Kern Kendrick, LLC's patent allowance rate?

70.7% of resolved applications prosecuted by Kern Kendrick, LLC were allowed, across 249 applications in USPTO records.

How many office actions does Kern Kendrick, LLC average before allowance?

2.56 office actions per allowed application on average.

How many pending office actions does Kern Kendrick, LLC have?

8 pending office actions as of October 2026, for 5 clients, before 8 examiners in 5 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month